Genprex, Inc. Stock Split Ratio
Genprex, Inc. (GNPX) reported Stock Split Ratio of 668.42% for the 3-month period ending 2019-03-31, per its 10-Q/A filed 2019-05-20.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-30
- Genprex, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2019-03-31 was 668.42%, a 0.00% change year-over-year.
- Genprex, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2018-03-31 was 668.42%.
- Genprex, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 668.42%, a 0.00% change from fiscal 2017.
- Genprex, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 668.42%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | 668.42% 10-Q/A · filed 2019-05-20 | |||||
| 2018-12-31 | 668.42% 10-K · filed 2019-04-01 | |||||
| 2018-09-30 | 668.42% 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | 668.42% 10-Q · filed 2018-08-14 | |||||
| 2018-04-30 | 668.42% 10-Q · filed 2019-11-14 | |||||
| 2018-04-03 | 668.42% 10-K · filed 2022-03-30 | |||||
| 2018-03-31 | 668.42% 10-Q · filed 2018-05-15 | |||||
| 2017-12-31 | 668.42% 10-K · filed 2018-04-17 | |||||
| 2017-09-30 | 668.42% 10-Q · filed 2017-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |